Omega-3 and Polyunsaturated Fatty Acid Interventions for Dry Eye Disease: An Umbrella Review of Clinical Efficacy, Evidence Quality and Overlap

Background and Objectives: Omega-3 and other polyunsaturated fatty acid (PUFA) interventions are used for dry eye disease (DED), yet reviews disagree about efficacy. We synthesised review-level evidence on clinical effects, methodological confidence and primary-study overlap. Materials and Methods: We searched Embase, Ovid MEDLINE, Ovid Emcare and the Cochrane Library for systematic reviews published from 2016 to June 2026 using title/abstract free-text terms. Two reviewers independently screened records and appraised reviews using AMSTAR 2. Findings were synthesised narratively; overlap was measured using corrected covered area (CCA). The review was retrospectively registered with the Open Science Framework. Results: Of 920 retrieved records, 542 were screened, 16 full texts assessed and 12 reviews included. Reported benefits were most frequent for symptoms and tear break-up time, but objective signs were inconsistent and several pooled estimates had extreme heterogeneity. Two reviews were rated high confidence, three moderate, one low and six critically low. Fifty unique primary studies contributed 155 occurrences (CCA 19.1%, very high overlap). The high-confidence reviews suggested small or uncertain benefits; a conservative AMSTAR 2 sensitivity analysis further reduced confidence in several reviews. Conclusions: The evidence does not support routine omega-3/PUFA treatment across DED phenotypes. Supplementation may be discussed as an optional adjunct, but statistically favourable results do not necessarily indicate clinically meaningful improvement. More rigorous phenotype-specific trials with standardised formulations, comparators and patient-centred outcomes are needed.

Authors

Institutions

Publication Details

Journal
Medicina
Published
2026-11-19
DOI
https://doi.org/10.3390/medicina62112276
Primary Topic
Ocular Surface and Contact Lens
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Omega-3 and Polyunsaturated Fatty Acid Interventions for Dry Eye Disease: An Umbrella Review of Clinical Efficacy, Evidence Quality and Overlap

Ninoshka Merchant, Devarsh Joshi
Medicina
Ocular Surface and Contact Lens
article

Omega-3 and Polyunsaturated Fatty Acid Interventions for Dry Eye Disease: An Umbrella Review of Clinical Efficacy, Evidence Quality and Overlap

Ninoshka Merchant, Devarsh Joshi
article en

Abstract

Background and Objectives: Omega-3 and other polyunsaturated fatty acid (PUFA) interventions are used for dry eye disease (DED), yet reviews disagree about efficacy. We synthesised review-level evidence on clinical effects, methodological confidence and primary-study overlap. Materials and Methods: We searched Embase, Ovid MEDLINE, Ovid Emcare and the Cochrane Library for systematic reviews published from 2016 to June 2026 using title/abstract free-text terms. Two reviewers independently screened records and appraised reviews using AMSTAR 2. Findings were synthesised narratively; overlap was measured using corrected covered area (CCA). The review was retrospectively registered with the Open Science Framework. Results: Of 920 retrieved records, 542 were screened, 16 full texts assessed and 12 reviews included. Reported benefits were most frequent for symptoms and tear break-up time, but objective signs were inconsistent and several pooled estimates had extreme heterogeneity. Two reviews were rated high confidence, three moderate, one low and six critically low. Fifty unique primary studies contributed 155 occurrences (CCA 19.1%, very high overlap). The high-confidence reviews suggested small or uncertain benefits; a conservative AMSTAR 2 sensitivity analysis further reduced confidence in several reviews. Conclusions: The evidence does not support routine omega-3/PUFA treatment across DED phenotypes. Supplementation may be discussed as an optional adjunct, but statistically favourable results do not necessarily indicate clinically meaningful improvement. More rigorous phenotype-specific trials with standardised formulations, comparators and patient-centred outcomes are needed.

MedicinaVol. 62(11)
Hampshire Hospitals NHS Foundation Trust (GB), Basingstoke and North Hampshire Hospital (GB)
Ocular Surface and Contact Lens
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon